EPA-Approved SARS-CoV-2 Disinfectants
6 rows where "Date_on_List_N" is on date 2020-10-29 sorted by Contact_time
json
Export this Data | Chart Risk Level by Product
Clear Chart
Add More Filters: Active_ingredient, Contact_time, Formulation_type,
ID
|
EPA_reg_num
|
Risk_level
|
Active_ingredient
|
Product_name
|
Company
|
Use_site
|
Surface_type
|
Contact_time ▼
|
Formulation_type
|
Follow_directions_for_this_virus
|
Date_on_List_N
|
Why_on_List_N
|
1045 |
1677-259 |
Safer |
Dodecylbenzenesulfonic acid; L-Lactic acid |
CW32A-RTU |
Ecolab Inc |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact No Rinse (FCNR) |
0.25 minutes |
Ready-to-use; Electrostatic spray |
SARS-CoV-2 |
2020-10-29 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1046 |
1677-260 |
Safer |
Dodecylbenzenesulfonic acid; L-Lactic acid |
S&S Sanitizer |
Ecolab Inc |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact No Rinse (FCNR) |
0.25 minutes |
Dilutable; Electrostatic spray |
SARS-CoV-2 |
2020-10-29 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1043 |
5813-21 |
Increased Risk |
Sodium hypochlorite |
Clorox Clean Up Cleaner + Bleach |
The Clorox Company |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
0.5 minutes |
Ready-to-use |
SARS-CoV-2 |
2020-10-29 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1044 |
67619-17 |
Increased Risk |
Sodium hypochlorite |
Clorox Commercial Solutions® Clorox® Clean-Up Disinfectant Cleaner with Bleach1 |
Clorox Professional Products Company |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
0.5 minutes |
Ready-to-use |
SARS-CoV-2 |
2020-10-29 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1041 |
10324-85 |
Increased Risk |
Quaternary ammonium |
Maquat 86-M |
Mason Chemical Company |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
1.0 minutes |
Ready-to-use |
SARS-CoV-2 |
2020-10-29 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1042 |
4091-21 |
Increased Risk |
Quaternary ammonium |
Condor 2 |
W.M. Barr & Company Inc |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Residual |
1.0 minutes |
Ready-to-use |
SARS-CoV-2 |
2020-10-29 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |